vs

Side-by-side financial comparison of 60 DEGREES PHARMACEUTICALS, INC. (SXTP) and TREASURE GLOBAL INC (TGL). Click either name above to swap in a different company.

60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $182.5K, roughly 1.7× TREASURE GLOBAL INC). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -1169.1%, a 694.9% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -12.0%). 60 DEGREES PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-1.8M vs $-2.4M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -83.5%).

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.

SXTP vs TGL — Head-to-Head

Bigger by revenue
SXTP
SXTP
1.7× larger
SXTP
$303.4K
$182.5K
TGL
Growing faster (revenue YoY)
SXTP
SXTP
+37.5% gap
SXTP
25.6%
-12.0%
TGL
Higher net margin
SXTP
SXTP
694.9% more per $
SXTP
-474.2%
-1169.1%
TGL
More free cash flow
SXTP
SXTP
$633.8K more FCF
SXTP
$-1.8M
$-2.4M
TGL
Faster 2-yr revenue CAGR
SXTP
SXTP
Annualised
SXTP
69.4%
-83.5%
TGL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
SXTP
SXTP
TGL
TGL
Revenue
$303.4K
$182.5K
Net Profit
$-1.4M
$-2.1M
Gross Margin
60.2%
0.7%
Operating Margin
-632.0%
-953.5%
Net Margin
-474.2%
-1169.1%
Revenue YoY
25.6%
-12.0%
Net Profit YoY
29.7%
-124.5%
EPS (diluted)
$-8.26
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SXTP
SXTP
TGL
TGL
Q4 25
$303.4K
Q3 25
$437.6K
$182.5K
Q2 25
$100.9K
$1.2M
Q1 25
$163.6K
$666.5K
Q4 24
$241.6K
$301.9K
Q3 24
$135.3K
$207.4K
Q2 24
$125.0K
$293.0K
Q1 24
$105.7K
$1.6M
Net Profit
SXTP
SXTP
TGL
TGL
Q4 25
$-1.4M
Q3 25
$-2.3M
$-2.1M
Q2 25
$-1.7M
Q1 25
$-1.9M
$1.3M
Q4 24
$-2.0M
$-232.3K
Q3 24
$-2.2M
$-950.7K
Q2 24
$-4.2M
Q1 24
$430.5K
$-1.7M
Gross Margin
SXTP
SXTP
TGL
TGL
Q4 25
60.2%
Q3 25
-22.9%
0.7%
Q2 25
50.4%
68.2%
Q1 25
55.2%
73.0%
Q4 24
51.1%
74.2%
Q3 24
17.4%
83.0%
Q2 24
28.3%
31.0%
Q1 24
38.1%
13.6%
Operating Margin
SXTP
SXTP
TGL
TGL
Q4 25
-632.0%
Q3 25
-531.4%
-953.5%
Q2 25
-1590.0%
Q1 25
-1168.4%
-6.5%
Q4 24
-854.7%
-229.5%
Q3 24
-1566.0%
-391.4%
Q2 24
-3351.8%
Q1 24
-1270.4%
-85.9%
Net Margin
SXTP
SXTP
TGL
TGL
Q4 25
-474.2%
Q3 25
-529.3%
-1169.1%
Q2 25
-1717.7%
Q1 25
-1147.4%
189.0%
Q4 24
-846.3%
-77.0%
Q3 24
-1596.4%
-458.5%
Q2 24
-3339.0%
Q1 24
407.4%
-107.3%
EPS (diluted)
SXTP
SXTP
TGL
TGL
Q4 25
$-8.26
Q3 25
$-0.66
$-0.38
Q2 25
$-1.25
Q1 25
$-1.56
$1.09
Q4 24
$-51.96
$-11.32
Q3 24
$-2.92
$-17.62
Q2 24
$-21.12
Q1 24
$1.83
$-116.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SXTP
SXTP
TGL
TGL
Cash + ST InvestmentsLiquidity on hand
$2.8M
Total DebtLower is stronger
$150.0K
Stockholders' EquityBook value
$3.5M
$12.0M
Total Assets
$5.4M
$16.6M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SXTP
SXTP
TGL
TGL
Q4 25
$2.8M
Q3 25
$4.1M
Q2 25
$2.0M
Q1 25
$3.5M
$2.5K
Q4 24
$3.4M
$504.3K
Q3 24
$5.0M
$44.1K
Q2 24
$1.6M
$171.6K
Q1 24
Total Debt
SXTP
SXTP
TGL
TGL
Q4 25
$150.0K
Q3 25
$150.0K
Q2 25
$150.0K
Q1 25
$150.0K
Q4 24
$150.0K
Q3 24
$150.0K
Q2 24
$150.0K
Q1 24
$150.0K
Stockholders' Equity
SXTP
SXTP
TGL
TGL
Q4 25
$3.5M
Q3 25
$4.4M
$12.0M
Q2 25
$2.4M
$10.7M
Q1 25
$4.1M
$29.1M
Q4 24
$4.0M
$18.4M
Q3 24
$6.0M
$6.3M
Q2 24
$3.0M
$3.4M
Q1 24
$7.2M
$3.1M
Total Assets
SXTP
SXTP
TGL
TGL
Q4 25
$5.4M
Q3 25
$6.7M
$16.6M
Q2 25
$4.2M
$14.9M
Q1 25
$6.0M
$30.4M
Q4 24
$5.8M
$19.1M
Q3 24
$7.4M
$7.1M
Q2 24
$4.3M
$4.3M
Q1 24
$8.4M
$4.2M
Debt / Equity
SXTP
SXTP
TGL
TGL
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.06×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.02×
Q2 24
0.05×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SXTP
SXTP
TGL
TGL
Operating Cash FlowLast quarter
$-1.7M
$-1.8M
Free Cash FlowOCF − Capex
$-1.8M
$-2.4M
FCF MarginFCF / Revenue
-584.2%
-1318.2%
Capex IntensityCapex / Revenue
26.3%
353.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SXTP
SXTP
TGL
TGL
Q4 25
$-1.7M
Q3 25
$-2.1M
$-1.8M
Q2 25
$-1.5M
$-9.5M
Q1 25
$-1.6M
$-4.2M
Q4 24
$-1.6M
$-606.2K
Q3 24
$-1.7M
$-976.3K
Q2 24
$-1.2M
$-4.7M
Q1 24
$-1.1M
$-1.1M
Free Cash Flow
SXTP
SXTP
TGL
TGL
Q4 25
$-1.8M
Q3 25
$-2.1M
$-2.4M
Q2 25
$-1.5M
$-9.5M
Q1 25
$-1.6M
$-4.2M
Q4 24
Q3 24
$-1.7M
Q2 24
$-4.7M
Q1 24
$-1.1M
FCF Margin
SXTP
SXTP
TGL
TGL
Q4 25
-584.2%
Q3 25
-484.2%
-1318.2%
Q2 25
-1483.6%
-822.4%
Q1 25
-978.3%
-635.6%
Q4 24
Q3 24
-1252.8%
Q2 24
-1614.2%
Q1 24
-67.1%
Capex Intensity
SXTP
SXTP
TGL
TGL
Q4 25
26.3%
Q3 25
2.3%
353.3%
Q2 25
46.9%
1.3%
Q1 25
1.6%
0.3%
Q4 24
Q3 24
10.2%
Q2 24
5.7%
Q1 24
0.0%
Cash Conversion
SXTP
SXTP
TGL
TGL
Q4 25
Q3 25
Q2 25
Q1 25
-3.36×
Q4 24
Q3 24
Q2 24
Q1 24
-2.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons